SLXN
Silexion Therapeutics
$0.14
−$0.01 (−7.19%)Oct 29, 2026
Key metrics
The numbers that frame SLXN today
- Market cap
- $789.56K
- ROIC
- -3,594.7%
- Div yield
- 0%
- Debt / equity
- 32.0
- 52wk Low
- $0.14
- 52wk High
- $34.70
Growth
Revenue and earnings trend for SLXN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about SLXN
Is Silexion Therapeutics a good buy?
No. Silexion Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup.
What is the market capitalization of SLXN?
Silexion Therapeutics's market capitalization is $789.56K.
What is the 52-week high for SLXN stock?
The 52-week high for Silexion Therapeutics is $34.70. The current close of $0.14 is 99.6% below that high.
What is the 52-week low for SLXN stock?
The 52-week low for Silexion Therapeutics is $0.14. The current close of $0.14 is 0% above that low.
Does SLXN stock pay dividends?
Silexion Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for SLXN?
Silexion Therapeutics's Debt / Equity ratio is 32.05.